Prior to final Food and Drug Administration approval in August, UH, MetroHealth and the Cleveland Clinic gained access to the ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially dose-limiting adverse effect of platinum-based chemotherapies that features pain and sensory deficits in the periphery.

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages Northwestern University economist ...

ABC News' correspondent Will Reeve is opening up for the first time about receiving a cancer diagnosis just months after ...

One of the most effective and widely used chemotherapy drugs in the world is also one of the most feared for a side effect ...

The application is supported by the phase 3 SAFFRON trial, in which savolitinib plus osimertinib improved progression-free ...

Reeve opens up about a deeply personal health battle he’s been facing for months and shares why he chose to make his journey ...

Hemangiosarcoma is one of the most feared diagnoses in veterinary medicine. This aggressive cancer of blood vessel cells, ...

Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or ...

The same drugs powerful enough to kill cancer cells can also damage healthy tissue. UC Irvine researchers are trying to ...

Merck & Co., Inc. (NYSE:MRK) and Daiichi Sankyo announced on September 25 that they voluntarily withdrew the U.S. application ...

Survivors and experts who have spoken with CURE share what to do before your first infusion, from saving your hair and protecting your skin to building a support team. The good news is that patients ...